Back
61
Day Range
$30.20
$32.91
52-Week Range
$13.45
$39.28
Volume
1,972,579
50D / 200D Avg
$33.65
/
$29.03
Prev Close
$32.75
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -24.4 | 0.4 |
| P/B | 2.7 | 2.9 |
| ROE % | -10.9 | 3.8 |
| Net Margin % | -52.0 | 3.9 |
| Rev Growth 5Y % | 67.3 | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Revenue grew 67.27% annually over 5 years — strong growth
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -73.47M
PEG of 0.43 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 2957.16%
Capital efficient — spends only 1.08% of revenue on capex
Growth
Revenue Growth (5Y)
67.27%
Revenue (1Y)3024.43%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-10.92%
ROIC-11.37%
Net Margin-51.99%
Op. Margin-72.84%
Safety
Debt / Equity
0.03
Current Ratio11.34
Interest Coverage0.00
Valuation
P/E Ratio
-24.44
P/B Ratio2.72
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3024.43% | Revenue Growth (3Y) | 205.82% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 67.27% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 218.71M | Net Income (TTM) | -113.70M |
| ROE | -10.92% | ROA | -10.25% |
| Gross Margin | 97.90% | Operating Margin | -72.84% |
| Net Margin | -51.99% | Free Cash Flow (TTM) | -73.47M |
| ROIC | -11.37% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 11.34 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -24.44 | P/B Ratio | 2.72 |
| P/S Ratio | 12.70 | PEG Ratio | 0.43 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.78B | Enterprise Value | 2.69B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 218.71M | 7.00M | 23.39M | 50.93M | 27.94M |
| Net Income | -113.70M | -274.48M | -112.96M | -58.66M | -49.76M |
| EPS (Diluted) | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 |
| Gross Profit | 214.12M | 3.17M | 19.38M | 48.83M | 26.22M |
| Operating Income | -159.31M | -326.98M | -134.43M | -62.50M | -50.27M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.11B | 1.12B | 649.32M | 387.97M | 381.35M |
| Total Liabilities | 86.39M | 64.94M | 28.23M | 38.51M | 79.83M |
| Shareholders' Equity | 1.02B | 1.06B | 621.09M | 349.46M | 301.51M |
| Total Debt | 27.91M | 19.17M | 2.87M | 3.48M | 5.18M |
| Cash & Equivalents | 112.83M | 84.38M | 157.02M | 68.63M | 92.05M |
| Current Assets | 666.73M | 689.71M | 532.63M | 370.45M | 251.00M |
| Current Liabilities | 58.82M | 46.07M | 27.10M | 31.72M | 45.16M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#30 of 146
Recent Activity
Entered
Full Throttle
Mar 24, 2026